Clinical trial
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver…
NCT00080236 · Conatus Pharmaceuticals Inc., Industry · Completed
Key facts
| NCT number | NCT00080236 |
|---|---|
| Title | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation |
| Official title | Safety, Tolerability and Efficacy Study of a Caspase Inhibitor, IDN-6556, in Patients Undergoing Orthotopic Liver Transplantation (OLT) |
| Lead sponsor | Conatus Pharmaceuticals Inc., Industry |
| Collaborators | Idun Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Transplantation, Hepatitis, Cholestasis, Carcinoma, Hepatocellular |
| Intervention type | Drug |
| Interventions | IDN-6556, Placebo |
| Enrollment | 99 |
| Start date | Nov 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Mar 26, 2004 |
| Last update posted | Aug 10, 2012 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: